Overall Count and Share for 'Biocon Bristol-Myers Squibb Research and Development Center (BBRC)' based on the 12-month time frame mentioned above. Note: Articles may be assigned to more than one ...
MUMBAI, Sept 27 (Reuters) - Biocon Ltd said on Monday it had strengthened its existing research partnership with Cuba-based Center of Molecular Immunology (CMI) to create a product pipeline focused on ...
Q3 Healthcare Results Preview: Motilal Oswal sees strong Q3 for Laurus Labs, Biocon; hospitals to drive sector momentum ...
He will also participate in a fireside chat at the ENDPOINTS at JPM26 conference on Tuesday, January 13 titled, "Achieving ...
Biocon Limited unveils three new oncology biosimilars at a US conference, expanding its global portfolio and advancing ...
BRIDGEWATER, N.J. and BENGALURU, India, Oct. 16, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: ...
BANGALORE, April 19 (Reuters) - India's largest biotechnology firm, Biocon Ltd. , sees strong growth in the current fiscal year on new drug discovery and large research outsourcing services contracts, ...
Biocon Biologics, a subsidiary of Biocon, received a European Union GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its new monoclonal antibodies (mAbs) drug ...
MUMBAI (MarketWatch) -- Biocon Ltd. (532523.BY), an Indian biotechnology company, Wednesday said that its unit, Syngene International Pvt. Ltd., has entered into a research tie-up with U.S.-based ...
Article ‘Count’ and ‘Share’ for Biocon Bristol-Myers Squibb Research and Development Center (BBRC) based on listed parameters only. The articles listed below published by authors from Biocon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback